Abstract 16597: Economic Evaluations of PCSK9 Inhibitors in Reducing Cardiovascular Risk From Societal & United States Payer Perspective Article

Nasir, Khurram, Arrieta, Alejandro, Veledar, Emir. (2015). Abstract 16597: Economic Evaluations of PCSK9 Inhibitors in Reducing Cardiovascular Risk From Societal & United States Payer Perspective . CIRCULATION, 132(suppl_3), 10.1161/circ.132.suppl_3.16597

cited authors

  • Nasir, Khurram; Arrieta, Alejandro; Veledar, Emir

authors

publication date

  • November 10, 2015

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3201 Cardiovascular Medicine and Haematology
  • 3202 Clinical Sciences
  • 6.1 Pharmaceuticals
  • Cardiovascular
  • Clinical Research
  • Cost Effectiveness Research
  • Health Disparities
  • Health Services
  • Heart Disease
  • Prevention
  • Social Determinants of Health

Digital Object Identifier (DOI)

publisher

  • Wolters Kluwer

volume

  • 132

issue

  • suppl_3